Navigation Links
CSA Medical Appoints William H. Floyd President and CEO
Date:12/2/2010

BALTIMORE, Dec. 2, 2010 /PRNewswire/ -- CSA Medical, Inc. (www.CSAmedical.com) today announced the appointment of William H. Floyd as incoming president, CEO and member of the board of directors. Floyd brings to the company more than 20 years of medical device experience, including market development roles commercializing disposables, implants, capital equipment and monitoring systems.

"We are thrilled to have Bill join the company and lead our efforts to create a world class medical device company," said Vince Owens, Chairman of the CSA Medical board of directors. "The company has made steady progress growing our customer and procedure base, and we believe that Bill has the background and experience needed to take our business to the next level of commercialization, including leading product development, clinical trials, regulatory, sales and marketing."

Prior to joining CSA Medical, Bill served as vice president of U.S. sales for Covidien following the sale of Aspect Medical Systems to Covidien in 2009. Previously, he was executive vice president of worldwide sales and marketing at Aspect Medical Systems, Inc.  Throughout a seven-year period, he managed Aspect from $19 million in revenue and a $20 million operating loss to more than $110 million in revenue and $16 million operating profit. Earlier in his career, Bill spent five years serving as vice president of marketing at Boston Scientific. In this position, he developed and executed the urology division's five year strategic plan focused on growth and diversification.  His efforts led to two acquisitions and numerous licensing and distribution agreements.  Previously, Bill held numerous senior sales and marketing positions with Johnson & Johnson (Codman & Shurtleff) and Procter and Gamble. Bill earned a bachelor's degree from the University of Vermont.

"CSA Medical's spray cryotherapy is a tremendously exciting new technology that holds promise to stop disease processes and dramatically improve the quality of life for millions of patients," said Floyd.  "I look forward to working with our team to bring the benefits of this technology to more patients across the globe as we expand our customer and procedure base."

CSA Medical, Inc develops and manufactures a proprietary therapeutic interventional treatment platform, the CryoSpray Ablation™ System, that delivers therapeutic doses of a cryogen to flash freeze and destroy diseased tissue inside the body. The Company is the first to harness the power of extreme cold (-196 C) liquid nitrogen therapeutic energy delivery inside the body. To learn more, please visit www.CSAmedical.com.


'/>"/>
SOURCE CSA Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cayenne Medical, Inc. Reaches 50,000 Implant Milestone
2. A Platform Technology to Address Bioterrorism Released by Aethlon Medical, Inc.
3. Draeger Teams Up with International Aid to Supply Medical Equipment for Use in Developing Countries
4. Philips and Atom Medical Corporation Announce Strategic Alliance to Provide a Complete Neonatal and Perinatal Offering
5. UBM Electronics EE Times and EDN Partner with Medical Electronics Design, MD+DI, and Others on DesignMED Event for Designers of Medical Electronics Devices
6. Reportlinker Adds Healthcare Reform: 2010 Medical Device Industry Perceptions Survey
7. Varian Medical Systems to Display Medical X-Ray Tubes and PaxScan® Digital X-Ray Image Detectors at MEDICA 2010 International Trade Fair
8. Reportlinker Adds Global Medical Oxygen Systems Industry
9. China Medical Technologies Reports Second Fiscal Quarter Financial Results
10. Misonix Announces Achievement of Contract Vendor Status With Select Medical Corporation
11. Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... DUBLIN , Feb. 24, 2017 Research and ... Analysis & Trends - Industry Forecast to 2025" report to their ... The Global Empty ... over the next decade to reach approximately $2.9 billion by 2025. ... all the given segments on global as well as regional levels presented ...
(Date:2/24/2017)... 2017 Medical information groups within the ... self-service capabilities to manage inquiries from external stakeholders ... New research from consulting leader Best Practices, LLC ... website portals where HCPs can sign on and ... many findings to emerge from the new study ...
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
Breaking Medicine Technology:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... and hearing disabilities, it is so critically important that we all are aware ... That is why Mediaplanet is proud to announce the launch of its newest ...
(Date:2/24/2017)... Abilene, Texas (PRWEB) , ... February 24, 2017 , ... ... article that focuses on Bible Prophecy concerning this present generation. Yisrayl makes an ... of this current generation. He explains that the Bible details the current times ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Senior International Elite division on February 12th. Ms. Esparza qualified into this ... elite qualifier competition held in Las Vegas, Nevada. Frida is one of approximately ...
(Date:2/23/2017)... Miami, FL (PRWEB) , ... February 23, 2017 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – will return to the La Gorce Country Club in Miami Beach ...
(Date:2/23/2017)... ... 23, 2017 , ... Rosica Communications, a national PR ... media management, corporate communications, SEO and cause marketing, is opening an office in ... Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. , ...
Breaking Medicine News(10 mins):